Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis model. Häusler D, Nessler S, Kruse N, Brück W, Metz I Neuropathol Appl Neurobiol. 2015 Jan 13. PMID: 25641089. Abstract CommentRecommendBookmarkWatch